Vir Biotechnology
VIR
Vir Biotechnology (VIR) - P/B ratio
P/B ratio as of September 2023 : 0.6860
According to Vir Biotechnology
's latest financial reports the company has a price-to-book ratio of 0.6860.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Vir Biotechnology - P/B ratio (from 2019 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 1.62 | -57.64% |
| 2021-12-31 | 3.83 | -19.58% |
| 2020-12-31 | 4.76 | 46.28% |
| 2019-12-31 | 3.25 | |
| 2018-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 1.43 | 108.20% | 🇺🇸 USA |